Growth Metrics

Baxter International (BAX) Cost of Revenue (2016 - 2024)

Baxter International (BAX) has disclosed Cost of Revenue for 16 consecutive years, with $1.8 billion as the latest value for Q4 2024.

  • On a quarterly basis, Cost of Revenue rose 247.65% to $1.8 billion in Q4 2024 year-over-year; TTM through Dec 2024 was $7.3 billion, a 18.0% increase, with the full-year FY2025 number at $7.9 billion, up 18.24% from a year prior.
  • Cost of Revenue was $1.8 billion for Q4 2024 at Baxter International, up from $1.7 billion in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $2.6 billion in Q2 2023 to a low of -$1.2 billion in Q4 2023.
  • A 5-year average of $1.7 billion and a median of $1.9 billion in 2021 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: crashed 142.26% in 2022, then soared 247.65% in 2024.
  • Baxter International's Cost of Revenue stood at $2.0 billion in 2020, then fell by 6.78% to $1.9 billion in 2021, then plummeted by 142.26% to -$784.0 million in 2022, then crashed by 54.97% to -$1.2 billion in 2023, then skyrocketed by 247.65% to $1.8 billion in 2024.
  • Per Business Quant, the three most recent readings for BAX's Cost of Revenue are $1.8 billion (Q4 2024), $1.7 billion (Q3 2024), and $1.7 billion (Q2 2024).